top of page
  • Writer's pictureDr. Dan Jin

CBD oxidation product HU-331 is a potential anticancer therapeutic


One recent study reviewed the literature related to the anticancer activity of HU-331, a CBD oxidation product, in purified systems, cancer cell lines, and animal models. The study concluded that HU-331 displays anticancer activity without some of the known adverse events associated with traditional anticancer agents.

7 views0 comments

Comments


PARTNER WITH US

Got a project?
Let’s talk.

We’re a team of scientists who are excited about unique ideas and help cannabis companies realize their product vision. 

Nutritional Supplements white label manufacturing - PBG
bottom of page